文献速递细胞病理与分子病理神经与头颈病理

涎腺非诊断性FNA的恶性风险低于所有受检患者:米兰系统Milan I类分析

Nondiagnostic salivary gland FNAs are associated with decreased risk of malignancy compared with "all-comer" patients: Analysis of the Milan System for Reporting Salivary Gland Cytopathology with a focus on Milan I: Nondiagnostic.
PubMed 文献 · Cancer Cytopathol · 2022-05-31

该研究基于Emory机构2010年1月至2021年3月的819例涎腺细针穿刺(SGFNA)数据及50篇MSRSGC文献综述,分析Milan I类(非诊断性,ND)的恶性风险(ROM)。结果显示ND类总体随访ROM(4.1%)显著低于所有受检者(11.4%),非黏液性囊内容物ROM尤其低,且ND率与ND ROM无关。

要点

  • ND类SGFNA的总体ROM为4.1%,显著低于所有受检者的11.4%。
  • 非黏液性囊内容物的ND SGFNA恶性风险极低。
  • ND SGFNA的发生率与ND类的ROM无相关性。

核心结论

  • ND类涎腺FNA的恶性风险低于所有受检患者。
  • ND SGFNA的真实ROM可能最佳估计为4.1%。
  • 非黏液性囊内容物的SGFNA恶性风险尤其低。
  • ND SGFNA的发生率不影响ND类的ROM。

研究设计与样本

  • 回顾性分析Emory机构2010年1月至2021年3月的819例SGFNA。
  • 文献综述纳入50篇使用MSRSGC的研究,共13,129例SGFNA。
  • 计算各分类及所有受检者的总体ROM(OROM)和手术/流式细胞术随访ROM(FROM)。

主要发现

  • 非黏液性囊内容物占ND SGFNA的26.7%(28/105),7例手术随访均良性。
  • 文献综述中18.2%(2384/13129)为ND,26.6%(635/2384)有已知随访。
  • ND FNA的总FROM和OROM分别为15.7%和4.1%,显著低于所有受检者的24.9%和11.4%(p < .001)。
  • ND SGFNA的发生率与ND ROM之间无关系。

关键数值与推荐

  • MSRSGC报告Milan I类ND的ROM为25%。
  • 本研究ND类OROM为4.1%,FROM为15.7%。
  • 所有受检者OROM为11.4%,FROM为24.9%。
  • ND与所有受检者OROM比较p < .001。

临床怎么用

  • ND类涎腺FNA患者恶性风险较低,可结合临床随访。
  • 非黏液性囊内容物的ND结果恶性风险极低,可减少不必要手术。
  • ND率高低不提示ND类ROM高低,不应据此调整风险评估。

局限性

  • 文献综述中ND类有已知随访者仅26.6%,可能存在随访偏倚。
  • 研究为回顾性分析,部分病例随访信息不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) reports a 25% rate of malignancy (ROM) for the Milan I: Nondiagnostic (ND) category. We clarify the ROM of ND salivary gland fine-needle aspirations (SGFNAs) based on our institutional experience and review of the literature. METHODS: Overall risk of malignancy (OROM) and that for those with surgical/flow cytometric follow-up (FROM) for each category and "all-comers" were calculated for Emory SGFNAs from January 2010 through March 2021. From a literature review of 50 articles using MSRSGC, distribution of diagnoses, rates of follow-up, FROM, and OROM by category were calculated. FROMs and OROMs between ND FNAs and all-comers were compared. Milan I rate was compared with the ratio of Milan I OROM to all-comer OROM. RESULTS: Of 819 SGFNAs at Emory, 12.8% (n = 105/819) were ND. Thirty-two had known follow-up, with 12 (37.5%) being malignant. Nonmucinous cyst contents accounted for 26.7% of ND SGFNAs (n = 28/105); all 7 with surgical follow-up were benign. Of 50 MSRSGC studies, 18.2% (n = 2384/13,129) of SGFNAs were classified as ND, 26.6% (n = 635/2384) with known follow-up. Total FROM and OROM for ND FNAs (15.7% and 4.1%, respectively) were significantly lower than those for all-comers (24.9% and 11.4%, respectively) (p < .001). There was no relationship between rate of ND SGFNA and ND ROM. CONCLUSIONS: The ND category is associated with a lower ROM than that of all-comer SGFNA patients. The "true" ROM for ND SGFNAs is likely best estimated by the 4.1% OROM. SGFNAs showing nonmucinous cyst contents have a particularly low ROM. Rate of ND SGFNAs does not influence ND ROM.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Lui SK, Tenney T, Mullane PC, et al. Nondiagnostic salivary gland FNAs are associated with decreased risk of malignancy compared with "all-comer" patients: Analysis of the Milan System for Reporting Salivary Gland Cytopathology with a focus on Milan I: Nondiagnostic. Cancer Cytopathol. 2022. PMID: 35640089. doi:10.1002/cncy.22601

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。